GLSI - Greenwich LifeSciences, Inc.

Gainer Signal for 05-20-2022
Loading Chart GLSI

Stock Signal Information


Gainer Stock Signal: GLSI
Report Date: 05-20-2022
Company: Greenwich LifeSciences, Inc. (GLSI)
Sector: Healthcare
Industry: Biotechnology

GLSI Technical Analysis

Company Contact

Greenwich LifeSciences, Inc. (GLSI)
Building 14
Stafford, TX 77477
Phone: 832-819-3232
Website: http://greenwichlifesciences.com
CEO: Ms. Snehal S. Patel

GLSI, Greenwich LifeSciences, Inc.

GLSI Greenwich LifeSciences, Inc. Logo Image

NASDAQ, Nasdaq Global Select

Company Profile

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of cancer immunotherapies for breast cancer and other human epidermal growth factor receptor 2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent recurrence of breast cancer following surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was founded in 2006 and is based in Stafford, Texas.

Top Stock Signals

best trading signals, free stock market signals, stock option trading signals

About Top Stock Signals

Good stock signals have been found on this server. That is all we know.

Phone: +1 (407) 559-7228
Email: [email protected]

About Us | Newsletter | Members

Most Active
Top Gainers
Top Losers